Conductive Keratoplasty (CK) for Presbyopia
The ViewPoint CK System (Refractec) for conductive keratoplasty (CK), previously approved by the FDA as a device for treatment of hyperopia (farsightedness), was recently approved for treatment of presbyopia (age-associated loss of ability to view near objects)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Conductive Keratoplasty (CK) for Presbyopia
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1185
Article Code: 1185a
Date: June 21, 2004
Volume: 46
Pages: 49-50
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1185
Article Code: 1185a
Date: June 21, 2004
Volume: 46
Pages: 49-50
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)